0001209191-21-002948.txt : 20210111 0001209191-21-002948.hdr.sgml : 20210111 20210111164404 ACCESSION NUMBER: 0001209191-21-002948 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201211 FILED AS OF DATE: 20210111 DATE AS OF CHANGE: 20210111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Glickman Richard M CENTRAL INDEX KEY: 0001352637 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37410 FILM NUMBER: 21521282 MAIL ADDRESS: STREET 1: C/O ASPREVA PHARMACEUTICALS CORPORATION STREET 2: 1203-4464 MARKHAM STREET CITY: VICTORIA STATE: A1 ZIP: V8Z7X8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ESSA Pharma Inc. CENTRAL INDEX KEY: 0001633932 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: SUITE 720 STREET 2: 999 WEST BROADWAY CITY: VANCOUVER STATE: A1 ZIP: V5Z 1K5 BUSINESS PHONE: (778) 331-0962 MAIL ADDRESS: STREET 1: SUITE 720 STREET 2: 999 WEST BROADWAY CITY: VANCOUVER STATE: A1 ZIP: V5Z 1K5 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-11 0 0001633932 ESSA Pharma Inc. EPIX 0001352637 Glickman Richard M C/O ESSA PHARMA INC. 999 WEST BROADWAY, SUITE 720 VANCOUVER A1 V5Z 1K5 BRITISH COLUMBIA, CANADA 1 0 0 0 Stock Option (Right to Buy) 7.00 2020-12-11 4 A 0 25000 0.00 A 2030-12-11 Common Shares 25000 25000 D 25% of the options vest after 12 months from the date of grant, and the remaining 75% vest in 36 equal installments with the first installment vesting at the end of the 13th month and subsequent installments vesting on every one month anniversary thereafter. /s/ Richard Glickman 2021-01-11